News Sentiment

GLMD sentiment intelligence

Galmed Pharmaceuticals Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.55 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-2.5% over one week, -5.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Galmed unveils heart-targeted Aramchol in cardiac fibrosis push

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -2.5% Price reacting lower
Trend fit Trend inactive -5.9% over four weeks
Fair value -82.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 36
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 11
Stock Titan 10
PR Newswire 9
Market source 7
Investing.com Nigeria 3
timothysykes.com 3
Investing.com 2
dars.gov.et 2

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 16
Deals and strategy 11
Analyst action 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-58 of 58
PR Newswire Direct company coverage

Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition

Galmed Pharmaceuticals Ltd. has announced restructured acquisition terms for Colospan Ltd., allowing for the consummation of the acquisition. The revised agreement reduces immediate shareholder dilution by increasing the cash payment and structuring the remaining balance as a ris

Tone
Positive 71/100
Event
Deals and strategy
Published
22 Jun 2026 11:09
Source
PR Newswire
Stock Titan Direct company coverage

Galmed (NASDAQ: GLMD) completes Colospan acquisition with cash and earnout

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) has finalized its acquisition of Colospan Ltd. under revised financial terms, paying $3.3 million in cash upfront and up to $2.0 million in performance-based earnouts tied to future net sales, rather than issuing shares. This strategic m

Tone
Positive 65/100
Event
Deals and strategy
Published
22 Jun 2026 11:09
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Galmed completes acquisition of medical device firm Colospan By Investing.com

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) announced the completion of its acquisition of Colospan Ltd., a medical device company, after restructuring deal terms. The acquisition, which involved an increased cash payment and an earnout structure, comes as Galmed's stock has faced

Tone
Neutral 50/100
Event
Deals and strategy
Published
22 Jun 2026 09:10
Source
Investing.com Nigeria